Original Source(s)
Related Content
Ivarmacitinib Eased Refractory PCA: Case Report
Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.
May 20, 2026
-
4 min
AD Not Linked to Early CV Risk Markers
Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.
May 27, 2026
-
5 min
10 states that support physician work-life balance
These 10 states have paid family or medical leave programs and health, wellness, peer support, or monitoring resources available to physicians or other health professionals.
August 27, 2026
-
6 min
